No Azithromycine for CVD Risk Patients

german translation / full article

An observational study shows a small absolute increase in cardiovascular deaths in patients on a 5 day azithromycin regimen (most pronounced among patients with a high baseline risk of cardiovascular disease). Prescribing should be reconsidered in CVD risk patients

(State: 17.10.2012)

Latest Issue 7-8/2019

In Focus

  • Selenium in the Prevention of Malignant Tumors
  • Palliative Sedation – What the Family Physician Should Know
  • De-Individualizing in Primary Medical Health Care